YDES Stock Analysis: Buy, Sell, or Hold?
YDES - YD Bio Limited Ordinary Shares
$3.71
-1.09 (-22.71%)
▼
5d:
-20.39%
30d:
+70.97%
90d:
+21.04%
WAIT
LOW Confidence
Analysis Updated: Aug 31, 2026 12:00 AM ET
Get Alerted When YDES Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: YDES is down 20.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: YDES is down 20.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: YDES is currently trading at $3.71, which is considered slightly high relative to its 30-day fair value range of $2.13 to $4.16.
Technical Outlook: Technically, YDES is in a strong downtrend. Immediate support is located at $3.09, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 22.7% recently.
Market Sentiment: YDES scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YDES is in a strong downtrend. Immediate support is located at $3.09, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 22.7% recently.
Market Sentiment: YDES scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.13 -
$4.16
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
29.4%
All Signals
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-22.7%)
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.13 -
$4.16
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.09
Resistance Level
$5.00
Current Trend
Strong Downtrend
Technical data as of
Aug 31, 2026
Fundamental Context
Revenue Growth (YoY)
95.6%
Profit Margin
-276.6%
Share & Embed Analysis
Last updated: September 01, 2026 7:02 AM ET
Data refreshes hourly during market hours. Next update: 8:02 AM
Data refreshes hourly during market hours. Next update: 8:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YDES showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 52 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 46 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 42 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 44 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 38 SELL |